The Role of Bax in the 14-3-3γ Protection against Cardiomyocyte Damage Induced by LPS

LIU Dan,YIN Dong,SUN Dian,XU Min,HE Ming

DOI: https://doi.org/10.3969/j.issn.0253-9896.2012.12.013

2012-01-01

Abstract:Objective: To investigate the protective effect of 14-3-3γ on cardiomyocyte against lipopolysaccharide (LPS) injury, and the relationship with the suppression of Bax translocation into mitochondria. Methods: The primary neonatal SD rat cardiomyocytes were randomly divided into 4 groups: control group, cardiomyocytes treated with 10 mg/L LPS for 6 h (LPS group), pFLAG transfected into cardiomyocytes for 24 h (pFLAG+LPS group) and pFLAG-14-3-3γ transfected into cardiomyocytes for 24 h (pFLAG-14-3-3γ+LPS group). After treatment, the cell viability was analyzed by methyl thiazoyl tetrazolium (MTT), the activity of lactic acid dehydrogenase (LDH) and creatine phosphate kinase (CPK) were determined by auto-biochemistry analysator, apoptotic cells were measured by flow cytometry and levels of 14-3-3γ protein in cardiomyocytes, Bax protein in cytoplasm and mitochondria were detected by Western blotting. Results: Compared with control group, the cell viability was significantly reduced in cardiomyocytes treated with LPS (P < 0.01), LDH and CPK activities were significantly increased (P < 0.01), the apoptotic cell ratio was enhanced (P < 0.01) and then Bax translocation from cytoplasm to mitochondria was promoted. The elevated l4-3-3γ protein resulted by transfection of pFLAG-14-3-3γ reversed cardiomyocyte damage induced by LPS, and inhibited Bax translocation from cytoplasm to mitochondria. Conclusion: 14-3-3γ protects cardiomyocytes against LPS damage by inhibiting Bax translocation from cytoplasm to mitochondria.